Glenmark Pharmaceuticals on Tuesday said its unit has inked a marketing and distribution agreement with BeiGene to commercialise the latter’s oncology medicines, Tislelizumab and Zanubrutinib in India.
Glenmark Specialty SA, a unit of Mumbai-based drug maker, has inked exclusive marketing and
Glenmark inks agreement with BeiGene for marketing and distribution of cancer drugs in India financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.